ClinicalMetric / Countries / Greece / multiple sclerosis
← 🇬🇷 Greece Trials
🇬🇷 Greece Country × Condition

multiple sclerosis Clinical Trials in Greece

Active clinical trials for multiple sclerosis with research sites in Greece. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇬🇷 Greece

Active Trials in Greece (2)

NCT05003388 Phase 1
Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

Enrollment
15 pts
Country
🇬🇷 Greece
The Foundation for Orthopaedics and...
View Trial →
NCT04806568
Recruiting

MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis

Enrollment
180 pts
Country
🇬🇷 Greece
Aristotle University Of Thessalonik...
View Trial →

Frequently Asked Questions

How many multiple sclerosis clinical trials are active in Greece?
There are currently 2 active clinical trials for multiple sclerosis with sites in Greece, of which 2 are actively recruiting patients.
How can I join a multiple sclerosis clinical trial in Greece?
To join a multiple sclerosis clinical trial in Greece, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Greece directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple sclerosis trials in Greece?
Active multiple sclerosis trials in Greece span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Greece Trials → Global multiple sclerosis Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology